Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03620474 |
Recruitment Status :
Completed
First Posted : August 8, 2018
Last Update Posted : July 7, 2022
|
Sponsor:
Kiminori Kimura, MD
Collaborators:
Prism Pharma Co., Ltd.
Kyushu University
National Center for Global Health and Medicine, Japan
Japan Agency for Medical Research and Development
Ohara Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Kiminori Kimura, MD, Komagome Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 13, 2021 |
Actual Study Completion Date : | February 28, 2022 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):